Table 1.
PENTA 15 | PENTA 13 | |
---|---|---|
[mean (range)] | [mean (range)] | |
Number of patients | 23 | 14 |
Ethnicity | 16 African, 4 Caucasian, 2 Other* | African |
Age (years) | 1.8 (0.43–2.89) | 5.9 (2.14–12.84) |
Weight (kg) | 11.6 (7.4–15.9) | 23.8 (13.7–60.5) |
Height (cm) | 81 (62–98) | 115 (89–164) |
BMI (kg cm−2) | 17.8 (15.0–24.2) | 16.8 (13.8–22.4) |
Creatinine clearance (dl h−1) | 31.7 (16.4–50.4) | 81 (59–159) |
Male/Female | 12/11 | 8/6 |
Normal/Fasted | 8/5* | 14/0 |
Samples | 4–9 | 9 |
Administration route | Oral | |
Dosage form | 20 mg ml−1 solution | |
Dose | 8–16 mg kg−1 |
indicates missing data.